Current data on lamotrigine

We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seiz...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista de neurologiá 2000-06, Vol.30 Suppl 1, p.S120
1. Verfasser: Casas-Fernández, C
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page S120
container_title Revista de neurologiá
container_volume 30 Suppl 1
creator Casas-Fernández, C
description We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seizures. We review the adverse effects and emphasize the need to attain the desired dose after a slow, progressive increase in dosage, particularly when it is associated with valproic acid, since this therapeutic combination is very effective in refractory epilepsies. We also mention the favourable effect on the quality of life of the patients treated with this drug and in those in whom an obvious euthymic effect is seen, as well as the benefit observed in patients with mental retardation.
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_10904978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10904978</sourcerecordid><originalsourceid>FETCH-LOGICAL-g164t-e3c34218f1cf9a9a17ea7691371a7f247d9236d0f5d1748b94017395d6c4457a3</originalsourceid><addsrcrecordid>eNo1zr-KwkAQgPEtPNRTn0CQvEBgJjvJZEoJ3h8QbLSWMbsrERNlEwvf3sK76ut-fCMzhQwhBUCYmM--vwCQJYGxmSAIkHA5NcvqEaPvhsTpoMmtS67a3obYnJvOz81H0GvvF3-dmcPXZl_9pNvd92-13qZnLGhIva0tZVgGrIOoKLJXLgQto3LIiJ1ktnAQcodM5UkIkK3krqiJclY7M6u3e3-cWu-O99i0Gp_H_0v7AkXyNV4</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Current data on lamotrigine</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Casas-Fernández, C</creator><creatorcontrib>Casas-Fernández, C</creatorcontrib><description>We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seizures. We review the adverse effects and emphasize the need to attain the desired dose after a slow, progressive increase in dosage, particularly when it is associated with valproic acid, since this therapeutic combination is very effective in refractory epilepsies. We also mention the favourable effect on the quality of life of the patients treated with this drug and in those in whom an obvious euthymic effect is seen, as well as the benefit observed in patients with mental retardation.</description><identifier>ISSN: 0210-0010</identifier><identifier>PMID: 10904978</identifier><language>spa</language><publisher>Spain</publisher><subject>Adult ; Aged ; Anticonvulsants - adverse effects ; Child ; Child, Preschool ; Epilepsy - drug therapy ; Humans ; Infant ; Infant, Newborn ; Middle Aged ; Quality of Life ; Triazines - adverse effects</subject><ispartof>Revista de neurologiá, 2000-06, Vol.30 Suppl 1, p.S120</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10904978$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Casas-Fernández, C</creatorcontrib><title>Current data on lamotrigine</title><title>Revista de neurologiá</title><addtitle>Rev Neurol</addtitle><description>We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seizures. We review the adverse effects and emphasize the need to attain the desired dose after a slow, progressive increase in dosage, particularly when it is associated with valproic acid, since this therapeutic combination is very effective in refractory epilepsies. We also mention the favourable effect on the quality of life of the patients treated with this drug and in those in whom an obvious euthymic effect is seen, as well as the benefit observed in patients with mental retardation.</description><subject>Adult</subject><subject>Aged</subject><subject>Anticonvulsants - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Epilepsy - drug therapy</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Middle Aged</subject><subject>Quality of Life</subject><subject>Triazines - adverse effects</subject><issn>0210-0010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1zr-KwkAQgPEtPNRTn0CQvEBgJjvJZEoJ3h8QbLSWMbsrERNlEwvf3sK76ut-fCMzhQwhBUCYmM--vwCQJYGxmSAIkHA5NcvqEaPvhsTpoMmtS67a3obYnJvOz81H0GvvF3-dmcPXZl_9pNvd92-13qZnLGhIva0tZVgGrIOoKLJXLgQto3LIiJ1ktnAQcodM5UkIkK3krqiJclY7M6u3e3-cWu-O99i0Gp_H_0v7AkXyNV4</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>Casas-Fernández, C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20000601</creationdate><title>Current data on lamotrigine</title><author>Casas-Fernández, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g164t-e3c34218f1cf9a9a17ea7691371a7f247d9236d0f5d1748b94017395d6c4457a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anticonvulsants - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Epilepsy - drug therapy</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Middle Aged</topic><topic>Quality of Life</topic><topic>Triazines - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casas-Fernández, C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revista de neurologiá</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casas-Fernández, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current data on lamotrigine</atitle><jtitle>Revista de neurologiá</jtitle><addtitle>Rev Neurol</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>30 Suppl 1</volume><spage>S120</spage><pages>S120-</pages><issn>0210-0010</issn><abstract>We analyze the most usual characteristics of lamotrigine and review the current antiepileptic indications. Similarly, we consider current hypotheses as to the mode of action during seizures which initially were not considered to be the main indication for use of the drug, as occurs with absence seizures. We review the adverse effects and emphasize the need to attain the desired dose after a slow, progressive increase in dosage, particularly when it is associated with valproic acid, since this therapeutic combination is very effective in refractory epilepsies. We also mention the favourable effect on the quality of life of the patients treated with this drug and in those in whom an obvious euthymic effect is seen, as well as the benefit observed in patients with mental retardation.</abstract><cop>Spain</cop><pmid>10904978</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0210-0010
ispartof Revista de neurologiá, 2000-06, Vol.30 Suppl 1, p.S120
issn 0210-0010
language spa
recordid cdi_pubmed_primary_10904978
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Anticonvulsants - adverse effects
Child
Child, Preschool
Epilepsy - drug therapy
Humans
Infant
Infant, Newborn
Middle Aged
Quality of Life
Triazines - adverse effects
title Current data on lamotrigine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A22%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20data%20on%20lamotrigine&rft.jtitle=Revista%20de%20neurologi%C3%A1&rft.au=Casas-Fern%C3%A1ndez,%20C&rft.date=2000-06-01&rft.volume=30%20Suppl%201&rft.spage=S120&rft.pages=S120-&rft.issn=0210-0010&rft_id=info:doi/&rft_dat=%3Cpubmed%3E10904978%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10904978&rfr_iscdi=true